Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:56 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 247 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Human Papillomavirus Vaccine Clear all

Conditions: Cancer
Interventions: 4 Corners Rural Health Cancer Prevention; Behavioral
Lead sponsor: Klein Buendel, Inc.; Industry
Eligibility: 18 Years to 26 Years
Enrollment: 1,796 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 5
States / cities: Tucson, Arizona • Aurora, Colorado • Fort Collins, Colorado + 2 more

Conditions: Cervical Cancer
Interventions: Not listed
Lead sponsor: University of Louisville; Other
Eligibility: 13 Years and older · Female only
Enrollment: 136 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: HPV Vaccination, Uptake Vaccination, Series Completion
Interventions: PREVENT; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 335 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Human Papillomavirus Vaccination
Interventions: Not listed
Lead sponsor: Indiana University; Other
Eligibility: 13 Years to 17 Years
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Human Papillomavirus
Interventions: Participatory, Efficient; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Papillomavirus Infections, Cervical Intraepithelial Neoplasia, Carcinoma In Situ, Vulvar Neoplasms, Vulvar Diseases
Interventions: E7 TCR cells, Aldesleukin, Fludarabine, Cyclophosphamide, EKG, Biopsy, Chest CT and MRI or PET, PFT, Granisetron, Ondansetron, Droperidol, Prochlorperazine, Diphenoxylate HCL, Atropine sulfate, Codeine sulfate, Loperamide, Indomethacin, Acetaminophen, Diphenhydramine HCL, Hydroxyzine HCL, Meperidine; Biological · Drug · Diagnostic Test + 1 more
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 120 Years
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 2
States / cities: Bethesda, Maryland • New Brunswick, New Jersey

Conditions: Human Papilloma Virus Infection Type 11, Human Papilloma Virus Infection Type 16, Human Papilloma Virus Infection Type 18, Human Papilloma Virus Infection Type 6, Cervical Cancer, Genital Warts, Oropharyngeal Cancer
Interventions: Simple Reminder; Behavioral
Lead sponsor: Regenstrief Institute, Inc.; Other
Eligibility: 11 Years to 17 Years
Enrollment: 1,305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 5
States / cities: Indianapolis, Indiana

Conditions: Human Papilloma Virus
Interventions: Communication training, Communication training enhanced with standing orders optimization; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 9 Years to 12 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Cervical Cancer
Interventions: PVX7; Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Female only
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Birmingham, Alabama • Baltimore, Maryland

Conditions: Human Papilloma Virus
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: Not listed
Enrollment: 3,076 participants
Timeline: 2019
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Human Papillomavirus, Uterine Cervical Neoplasms
Interventions: Educational materials; Behavioral
Lead sponsor: Meharry Medical College; Other
Eligibility: 9 Years and older
Enrollment: 806 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Infections, Papillomavirus
Interventions: Data collection; Other
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 9 Years to 25 Years · Female only
Enrollment: 1,516 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Wilmington, Delaware

Conditions: Human Papillomavirus Infection
Interventions: Assessment Feedback Incentives and eXchange, Physician-to-physician engagement, Active Intervention Control; Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: Not listed
Enrollment: 264 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Phoenix, Arizona • Albany, New York • Madison, Wisconsin

Conditions: Human Papillomavirus Vaccination
Interventions: Text message reminder; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 10 Years to 14 Years · Female only
Enrollment: 154 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: Human Papilloma Virus
Interventions: Champion Announcement Approach Training, Traditional Announcement Approach Training; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 9 Years to 12 Years
Enrollment: 47 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Madison, Wisconsin

Conditions: Papillomavirus Vaccines
Interventions: HPV-PROTECT; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 9 Years and older
Enrollment: 8,120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 6
States / cities: Birmingham, Alabama • Atlanta, Georgia • Minneapolis, Minnesota + 3 more

Conditions: Human Papillomavirus Vaccination
Interventions: Text Message/automated phone reminder; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: 10 Years to 14 Years · Female only
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Human Papillomavirus (HPV)
Interventions: Provider assessment and feedback, Provider reminders, Provider education, Patient reminders, Parent education; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 11 Years to 17 Years
Enrollment: 1,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Human Papillomavirus Infections
Interventions: Ad26.HPV16, Ad26.HPV18, MVA.HPV16/18, Placebo; Biological
Lead sponsor: Janssen Vaccines & Prevention B.V.; Industry
Eligibility: 18 Years to 60 Years · Female only
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 11
States / cities: Doral, Florida • Fort Myers, Florida • Miami, Florida + 8 more

Conditions: Vaccination Hesitancy, Human Papillomavirus Vaccination, Vaccine Refusal
Interventions: Argument inoculation messages, Simple forewarning message; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 523 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: HIV Infections
Interventions: Quadrivalent HPV Vaccine, Placebo Vaccine for Male Participants Only, Placebo Vaccine for Female Participants Only; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 27 Years and older
Enrollment: 575 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 22
States / cities: Los Angeles, California • Palo Alto, California • San Diego, California + 14 more

Conditions: Hiv, Hpv
Interventions: Self-Collection HPV testing kit from Abbott; Diagnostic Test
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years to 40 Years · Female only
Enrollment: 650 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 9
States / cities: Denver, Colorado • Miami, Florida • Chicago, Illinois + 5 more

Conditions: HPV Vaccine, HPV
Interventions: Online survey, Focus groups or Individual Interviews, Interviews; Behavioral
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 155 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Warts, Verruca (Warts), Verruca Vulgaris
Interventions: 9-valent human papillomavirus vaccine, Sterile Saline; Biological · Other
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Cancer Prevention for Young Rural Adults

Health Care Decisions for Female Adolescents: The Role of Mothers and Daughters in Decision Making

PREVENT Pilot HPV - Related Cancers Trial

Parent-son-provider Decision-making About HPV Vaccination

Making Effective Human Papillomavirus (HPV) Vaccine Recommendations

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Impact of Standing Orders Optimization

A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients

SDH of HPV Vaccine Completion

An HPV Vaccine Provider Intervention in Safety Net Clinics

Post-marketing Safety Study of Autoimmune Diseases Following Cervarix® Vaccination

Quality Improvement Strategies to Increase Human Papillomavirus (HPV) Vaccination

SMS HPV Vaccine Reminders

Engaging Clinical Champions to Improve HPV Vaccination

Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors

HPV Vaccine Reminders - SEARCH II Study

Multi-component Interventions to Increase HPV Vaccination in a Network of Pediatric Clinics

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Testing the Persuasiveness of Pro-inoculation Arguments

Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

Adaptation Of An HPV Education Resource To Promote HPV Vaccination

Intralesional Gardasil-9 for the Treatment of Recalcitrant Warts